Global Recombinant Vector Vaccines Market Growth 2022-2028

1.1 Market Introduction

1.2 Years Considered

1.3 Research Objectives

1.4 Market Research Methodology

1.5 Research Process and Data Source

1.6 Economic Indicators

1.7 Currency Considered

2 Executive Summary

2.1 World Market Overview

2.1.1 Global Recombinant Vector Vaccines Annual Sales 2017-2028

2.1.2 World Current & Future Analysis for Recombinant Vector Vaccines by Geographic Region, 2017, 2022 & 2028

2.1.3 World Current & Future Analysis for Recombinant Vector Vaccines by Country/Region, 2017, 2022 & 2028

2.2 Recombinant Vector Vaccines Segment by Type

2.2.1 Varicella

2.2.2 Influenza

2.2.3 Polio

2.2.4 Hepatitis A

2.2.5 Rabies

2.2.6 BCG

2.2.7 Hepatitis B

2.2.8 Pertussis, Diphtheria, tetanus

2.2.9 Pneumococcal

2.2.10 Others

2.3 Recombinant Vector Vaccines Sales by Type

2.3.1 Global Recombinant Vector Vaccines Sales Market Share by Type (2017-2022)

2.3.2 Global Recombinant Vector Vaccines Revenue and Market Share by Type (2017-2022)

2.3.3 Global Recombinant Vector Vaccines Sale Price by Type (2017-2022)

2.4 Recombinant Vector Vaccines Segment by Application

2.4.1 For Adult

2.4.2 For Child

2.5 Recombinant Vector Vaccines Sales by Application

2.5.1 Global Recombinant Vector Vaccines Sale Market Share by Application (2017-2022)

2.5.2 Global Recombinant Vector Vaccines Revenue and Market Share by Application (2017-2022)

2.5.3 Global Recombinant Vector Vaccines Sale Price by Application (2017-2022)

3 Global Recombinant Vector Vaccines by Company

3.1 Global Recombinant Vector Vaccines Breakdown Data by Company

3.1.1 Global Recombinant Vector Vaccines Annual Sales by Company (2020-2022)

3.1.2 Global Recombinant Vector Vaccines Sales Market Share by Company (2020-2022)

3.2 Global Recombinant Vector Vaccines Annual Revenue by Company (2020-2022)

3.2.1 Global Recombinant Vector Vaccines Revenue by Company (2020-2022)

3.2.2 Global Recombinant Vector Vaccines Revenue Market Share by Company (2020-2022)

3.3 Global Recombinant Vector Vaccines Sale Price by Company

3.4 Key Manufacturers Recombinant Vector Vaccines Producing Area Distribution, Sales Area, Product Type

3.4.1 Key Manufacturers Recombinant Vector Vaccines Product Location Distribution

3.4.2 Players Recombinant Vector Vaccines Products Offered

3.5 Market Concentration Rate Analysis

3.5.1 Competition Landscape Analysis

3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

3.6 New Products and Potential Entrants

3.7 Mergers & Acquisitions, Expansion

4 World Historic Review for Recombinant Vector Vaccines by Geographic Region

4.1 World Historic Recombinant Vector Vaccines Market Size by Geographic Region (2017-2022)

4.1.1 Global Recombinant Vector Vaccines Annual Sales by Geographic Region (2017-2022)

4.1.2 Global Recombinant Vector Vaccines Annual Revenue by Geographic Region

4.2 World Historic Recombinant Vector Vaccines Market Size by Country/Region (2017-2022)

4.2.1 Global Recombinant Vector Vaccines Annual Sales by Country/Region (2017-2022)

4.2.2 Global Recombinant Vector Vaccines Annual Revenue by Country/Region

4.3 Americas Recombinant Vector Vaccines Sales Growth

4.4 APAC Recombinant Vector Vaccines Sales Growth

4.5 Europe Recombinant Vector Vaccines Sales Growth

4.6 Middle East & Africa Recombinant Vector Vaccines Sales Growth

5 Americas

5.1 Americas Recombinant Vector Vaccines Sales by Country

5.1.1 Americas Recombinant Vector Vaccines Sales by Country (2017-2022)

5.1.2 Americas Recombinant Vector Vaccines Revenue by Country (2017-2022)

5.2 Americas Recombinant Vector Vaccines Sales by Type

5.3 Americas Recombinant Vector Vaccines Sales by Application

5.4 United States

5.5 Canada

5.6 Mexico

5.7 Brazil

6 APAC

6.1 APAC Recombinant Vector Vaccines Sales by Region

6.1.1 APAC Recombinant Vector Vaccines Sales by Region (2017-2022)

6.1.2 APAC Recombinant Vector Vaccines Revenue by Region (2017-2022)

6.2 APAC Recombinant Vector Vaccines Sales by Type

6.3 APAC Recombinant Vector Vaccines Sales by Application

6.4 China

6.5 Japan

6.6 South Korea

6.7 Southeast Asia

6.8 India

6.9 Australia

6.10 China Taiwan

7 Europe

7.1 Europe Recombinant Vector Vaccines by Country

7.1.1 Europe Recombinant Vector Vaccines Sales by Country (2017-2022)

7.1.2 Europe Recombinant Vector Vaccines Revenue by Country (2017-2022)

7.2 Europe Recombinant Vector Vaccines Sales by Type

7.3 Europe Recombinant Vector Vaccines Sales by Application

7.4 Germany

7.5 France

7.6 UK

7.7 Italy

7.8 Russia

8 Middle East & Africa

8.1 Middle East & Africa Recombinant Vector Vaccines by Country

8.1.1 Middle East & Africa Recombinant Vector Vaccines Sales by Country (2017-2022)

8.1.2 Middle East & Africa Recombinant Vector Vaccines Revenue by Country (2017-2022)

8.2 Middle East & Africa Recombinant Vector Vaccines Sales by Type

8.3 Middle East & Africa Recombinant Vector Vaccines Sales by Application

8.4 Egypt

8.5 South Africa

8.6 Israel

8.7 Turkey

8.8 GCC Countries

9 Market Drivers, Challenges and Trends

9.1 Market Drivers & Growth Opportunities

9.2 Market Challenges & Risks

9.3 Industry Trends

10 Manufacturing Cost Structure Analysis

10.1 Raw Material and Suppliers

10.2 Manufacturing Cost Structure Analysis of Recombinant Vector Vaccines

10.3 Manufacturing Process Analysis of Recombinant Vector Vaccines

10.4 Industry Chain Structure of Recombinant Vector Vaccines

11 Marketing, Distributors and Customer

11.1 Sales Channel

11.1.1 Direct Channels

11.1.2 Indirect Channels

11.2 Recombinant Vector Vaccines Distributors

11.3 Recombinant Vector Vaccines Customer

12 World Forecast Review for Recombinant Vector Vaccines by Geographic Region

12.1 Global Recombinant Vector Vaccines Market Size Forecast by Region

12.1.1 Global Recombinant Vector Vaccines Forecast by Region (2023-2028)

12.1.2 Global Recombinant Vector Vaccines Annual Revenue Forecast by Region (2023-2028)

12.2 Americas Forecast by Country

12.3 APAC Forecast by Region

12.4 Europe Forecast by Country

12.5 Middle East & Africa Forecast by Country

12.6 Global Recombinant Vector Vaccines Forecast by Type

12.7 Global Recombinant Vector Vaccines Forecast by Application

13 Key Players Analysis

13.1 SANOFI PASTEUR S.A.

13.1.1 SANOFI PASTEUR S.A. Company Information

13.1.2 SANOFI PASTEUR S.A. Recombinant Vector Vaccines Product Offered

13.1.3 SANOFI PASTEUR S.A. Recombinant Vector Vaccines Sales, Revenue, Price and Gross Margin (2020-2022)

13.1.4 SANOFI PASTEUR S.A. Main Business Overview

13.1.5 SANOFI PASTEUR S.A. Latest Developments

13.2 Novartis

13.2.1 Novartis Company Information

13.2.2 Novartis Recombinant Vector Vaccines Product Offered

13.2.3 Novartis Recombinant Vector Vaccines Sales, Revenue, Price and Gross Margin (2020-2022)

13.2.4 Novartis Main Business Overview

13.2.5 Novartis Latest Developments

13.3 GSK

13.3.1 GSK Company Information

13.3.2 GSK Recombinant Vector Vaccines Product Offered

13.3.3 GSK Recombinant Vector Vaccines Sales, Revenue, Price and Gross Margin (2020-2022)

13.3.4 GSK Main Business Overview

13.3.5 GSK Latest Developments

13.4 CNBG

13.4.1 CNBG Company Information

13.4.2 CNBG Recombinant Vector Vaccines Product Offered

13.4.3 CNBG Recombinant Vector Vaccines Sales, Revenue, Price and Gross Margin (2020-2022)

13.4.4 CNBG Main Business Overview

13.4.5 CNBG Latest Developments

13.5 ChengDa Bio

13.5.1 ChengDa Bio Company Information

13.5.2 ChengDa Bio Recombinant Vector Vaccines Product Offered

13.5.3 ChengDa Bio Recombinant Vector Vaccines Sales, Revenue, Price and Gross Margin (2020-2022)

13.5.4 ChengDa Bio Main Business Overview

13.5.5 ChengDa Bio Latest Developments

13.6 Changsheng Life

13.6.1 Changsheng Life Company Information

13.6.2 Changsheng Life Recombinant Vector Vaccines Product Offered

13.6.3 Changsheng Life Recombinant Vector Vaccines Sales, Revenue, Price and Gross Margin (2020-2022)

13.6.4 Changsheng Life Main Business Overview

13.6.5 Changsheng Life Latest Developments

13.7 Zhifei

13.7.1 Zhifei Company Information

13.7.2 Zhifei Recombinant Vector Vaccines Product Offered

13.7.3 Zhifei Recombinant Vector Vaccines Sales, Revenue, Price and Gross Margin (2020-2022)

13.7.4 Zhifei Main Business Overview

13.7.5 Zhifei Latest Developments

13.8 SINOVAC BIOTECH

13.8.1 SINOVAC BIOTECH Company Information

13.8.2 SINOVAC BIOTECH Recombinant Vector Vaccines Product Offered

13.8.3 SINOVAC BIOTECH Recombinant Vector Vaccines Sales, Revenue, Price and Gross Margin (2020-2022)

13.8.4 SINOVAC BIOTECH Main Business Overview

13.8.5 SINOVAC BIOTECH Latest Developments

13.9 NuoCheng Bio

13.9.1 NuoCheng Bio Company Information

13.9.2 NuoCheng Bio Recombinant Vector Vaccines Product Offered

13.9.3 NuoCheng Bio Recombinant Vector Vaccines Sales, Revenue, Price and Gross Margin (2020-2022)

13.9.4 NuoCheng Bio Main Business Overview

13.9.5 NuoCheng Bio Latest Developments

13.10 Hualan Bio

13.10.1 Hualan Bio Company Information

13.10.2 Hualan Bio Recombinant Vector Vaccines Product Offered

13.10.3 Hualan Bio Recombinant Vector Vaccines Sales, Revenue, Price and Gross Margin (2020-2022)

13.10.4 Hualan Bio Main Business Overview

13.10.5 Hualan Bio Latest Developments

13.11 Kangtai

13.11.1 Kangtai Company Information

13.11.2 Kangtai Recombinant Vector Vaccines Product Offered

13.11.3 Kangtai Recombinant Vector Vaccines Sales, Revenue, Price and Gross Margin (2020-2022)

13.11.4 Kangtai Main Business Overview

13.11.5 Kangtai Latest Developments

14 Research Findings and Conclusion

Table 1. Recombinant Vector Vaccines Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)

Table 2. Recombinant Vector Vaccines Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)

Table 3. Major Players of Varicella

Table 4. Major Players of Influenza

Table 5. Major Players of Polio

Table 6. Major Players of Hepatitis A

Table 7. Major Players of Rabies

Table 8. Major Players of BCG

Table 9. Major Players of Hepatitis B

Table 10. Major Players of Pertussis, Diphtheria, tetanus

Table 11. Major Players of Pneumococcal

Table 12. Major Players of Others

Table 13. Global Recombinant Vector Vaccines Sales by Type (2017-2022) & (K Doses)

Table 14. Global Recombinant Vector Vaccines Sales Market Share by Type (2017-2022)

Table 15. Global Recombinant Vector Vaccines Revenue by Type (2017-2022) & ($ million)

Table 16. Global Recombinant Vector Vaccines Revenue Market Share by Type (2017-2022)

Table 17. Global Recombinant Vector Vaccines Sale Price by Type (2017-2022) & (USD/Dose)

Table 18. Global Recombinant Vector Vaccines Sales by Application (2017-2022) & (K Doses)

Table 19. Global Recombinant Vector Vaccines Sales Market Share by Application (2017-2022)

Table 20. Global Recombinant Vector Vaccines Revenue by Application (2017-2022)

Table 21. Global Recombinant Vector Vaccines Revenue Market Share by Application (2017-2022)

Table 22. Global Recombinant Vector Vaccines Sale Price by Application (2017-2022) & (USD/Dose)

Table 23. Global Recombinant Vector Vaccines Sales by Company (2020-2022) & (K Doses)

Table 24. Global Recombinant Vector Vaccines Sales Market Share by Company (2020-2022)

Table 25. Global Recombinant Vector Vaccines Revenue by Company (2020-2022) ($ Millions)

Table 26. Global Recombinant Vector Vaccines Revenue Market Share by Company (2020-2022)

Table 27. Global Recombinant Vector Vaccines Sale Price by Company (2020-2022) & (USD/Dose)

Table 28. Key Manufacturers Recombinant Vector Vaccines Producing Area Distribution and Sales Area

Table 29. Players Recombinant Vector Vaccines Products Offered

Table 30. Recombinant Vector Vaccines Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

Table 31. New Products and Potential Entrants

Table 32. Mergers & Acquisitions, Expansion

Table 33. Global Recombinant Vector Vaccines Sales by Geographic Region (2017-2022) & (K Doses)

Table 34. Global Recombinant Vector Vaccines Sales Market Share Geographic Region (2017-2022)

Table 35. Global Recombinant Vector Vaccines Revenue by Geographic Region (2017-2022) & ($ millions)

Table 36. Global Recombinant Vector Vaccines Revenue Market Share by Geographic Region (2017-2022)

Table 37. Global Recombinant Vector Vaccines Sales by Country/Region (2017-2022) & (K Doses)

Table 38. Global Recombinant Vector Vaccines Sales Market Share by Country/Region (2017-2022)

Table 39. Global Recombinant Vector Vaccines Revenue by Country/Region (2017-2022) & ($ millions)

Table 40. Global Recombinant Vector Vaccines Revenue Market Share by Country/Region (2017-2022)

Table 41. Americas Recombinant Vector Vaccines Sales by Country (2017-2022) & (K Doses)

Table 42. Americas Recombinant Vector Vaccines Sales Market Share by Country (2017-2022)

Table 43. Americas Recombinant Vector Vaccines Revenue by Country (2017-2022) & ($ Millions)

Table 44. Americas Recombinant Vector Vaccines Revenue Market Share by Country (2017-2022)

Table 45. Americas Recombinant Vector Vaccines Sales by Type (2017-2022) & (K Doses)

Table 46. Americas Recombinant Vector Vaccines Sales Market Share by Type (2017-2022)

Table 47. Americas Recombinant Vector Vaccines Sales by Application (2017-2022) & (K Doses)

Table 48. Americas Recombinant Vector Vaccines Sales Market Share by Application (2017-2022)

Table 49. APAC Recombinant Vector Vaccines Sales by Region (2017-2022) & (K Doses)

Table 50. APAC Recombinant Vector Vaccines Sales Market Share by Region (2017-2022)

Table 51. APAC Recombinant Vector Vaccines Revenue by Region (2017-2022) & ($ Millions)

Table 52. APAC Recombinant Vector Vaccines Revenue Market Share by Region (2017-2022)

Table 53. APAC Recombinant Vector Vaccines Sales by Type (2017-2022) & (K Doses)

Table 54. APAC Recombinant Vector Vaccines Sales Market Share by Type (2017-2022)

Table 55. APAC Recombinant Vector Vaccines Sales by Application (2017-2022) & (K Doses)

Table 56. APAC Recombinant Vector Vaccines Sales Market Share by Application (2017-2022)

Table 57. Europe Recombinant Vector Vaccines Sales by Country (2017-2022) & (K Doses)

Table 58. Europe Recombinant Vector Vaccines Sales Market Share by Country (2017-2022)

Table 59. Europe Recombinant Vector Vaccines Revenue by Country (2017-2022) & ($ Millions)

Table 60. Europe Recombinant Vector Vaccines Revenue Market Share by Country (2017-2022)

Table 61. Europe Recombinant Vector Vaccines Sales by Type (2017-2022) & (K Doses)

Table 62. Europe Recombinant Vector Vaccines Sales Market Share by Type (2017-2022)

Table 63. Europe Recombinant Vector Vaccines Sales by Application (2017-2022) & (K Doses)

Table 64. Europe Recombinant Vector Vaccines Sales Market Share by Application (2017-2022)

Table 65. Middle East & Africa Recombinant Vector Vaccines Sales by Country (2017-2022) & (K Doses)

Table 66. Middle East & Africa Recombinant Vector Vaccines Sales Market Share by Country (2017-2022)

Table 67. Middle East & Africa Recombinant Vector Vaccines Revenue by Country (2017-2022) & ($ Millions)

Table 68. Middle East & Africa Recombinant Vector Vaccines Revenue Market Share by Country (2017-2022)

Table 69. Middle East & Africa Recombinant Vector Vaccines Sales by Type (2017-2022) & (K Doses)

Table 70. Middle East & Africa Recombinant Vector Vaccines Sales Market Share by Type (2017-2022)

Table 71. Middle East & Africa Recombinant Vector Vaccines Sales by Application (2017-2022) & (K Doses)

Table 72. Middle East & Africa Recombinant Vector Vaccines Sales Market Share by Application (2017-2022)

Table 73. Key Market Drivers & Growth Opportunities of Recombinant Vector Vaccines

Table 74. Key Market Challenges & Risks of Recombinant Vector Vaccines

Table 75. Key Industry Trends of Recombinant Vector Vaccines

Table 76. Recombinant Vector Vaccines Raw Material

Table 77. Key Suppliers of Raw Materials

Table 78. Recombinant Vector Vaccines Distributors List

Table 79. Recombinant Vector Vaccines Customer List

Table 80. Global Recombinant Vector Vaccines Sales Forecast by Region (2023-2028) & (K Doses)

Table 81. Global Recombinant Vector Vaccines Sales Market Forecast by Region

Table 82. Global Recombinant Vector Vaccines Revenue Forecast by Region (2023-2028) & ($ millions)

Table 83. Global Recombinant Vector Vaccines Revenue Market Share Forecast by Region (2023-2028)

Table 84. Americas Recombinant Vector Vaccines Sales Forecast by Country (2023-2028) & (K Doses)

Table 85. Americas Recombinant Vector Vaccines Revenue Forecast by Country (2023-2028) & ($ millions)

Table 86. APAC Recombinant Vector Vaccines Sales Forecast by Region (2023-2028) & (K Doses)

Table 87. APAC Recombinant Vector Vaccines Revenue Forecast by Region (2023-2028) & ($ millions)

Table 88. Europe Recombinant Vector Vaccines Sales Forecast by Country (2023-2028) & (K Doses)

Table 89. Europe Recombinant Vector Vaccines Revenue Forecast by Country (2023-2028) & ($ millions)

Table 90. Middle East & Africa Recombinant Vector Vaccines Sales Forecast by Country (2023-2028) & (K Doses)

Table 91. Middle East & Africa Recombinant Vector Vaccines Revenue Forecast by Country (2023-2028) & ($ millions)

Table 92. Global Recombinant Vector Vaccines Sales Forecast by Type (2023-2028) & (K Doses)

Table 93. Global Recombinant Vector Vaccines Sales Market Share Forecast by Type (2023-2028)

Table 94. Global Recombinant Vector Vaccines Revenue Forecast by Type (2023-2028) & ($ Millions)

Table 95. Global Recombinant Vector Vaccines Revenue Market Share Forecast by Type (2023-2028)

Table 96. Global Recombinant Vector Vaccines Sales Forecast by Application (2023-2028) & (K Doses)

Table 97. Global Recombinant Vector Vaccines Sales Market Share Forecast by Application (2023-2028)

Table 98. Global Recombinant Vector Vaccines Revenue Forecast by Application (2023-2028) & ($ Millions)

Table 99. Global Recombinant Vector Vaccines Revenue Market Share Forecast by Application (2023-2028)

Table 100. SANOFI PASTEUR S.A. Basic Information, Recombinant Vector Vaccines Manufacturing Base, Sales Area and Its Competitors

Table 101. SANOFI PASTEUR S.A. Recombinant Vector Vaccines Product Offered

Table 102. SANOFI PASTEUR S.A. Recombinant Vector Vaccines Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2020-2022)

Table 103. SANOFI PASTEUR S.A. Main Business

Table 104. SANOFI PASTEUR S.A. Latest Developments

Table 105. Novartis Basic Information, Recombinant Vector Vaccines Manufacturing Base, Sales Area and Its Competitors

Table 106. Novartis Recombinant Vector Vaccines Product Offered

Table 107. Novartis Recombinant Vector Vaccines Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2020-2022)

Table 108. Novartis Main Business

Table 109. Novartis Latest Developments

Table 110. GSK Basic Information, Recombinant Vector Vaccines Manufacturing Base, Sales Area and Its Competitors

Table 111. GSK Recombinant Vector Vaccines Product Offered

Table 112. GSK Recombinant Vector Vaccines Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2020-2022)

Table 113. GSK Main Business

Table 114. GSK Latest Developments

Table 115. CNBG Basic Information, Recombinant Vector Vaccines Manufacturing Base, Sales Area and Its Competitors

Table 116. CNBG Recombinant Vector Vaccines Product Offered

Table 117. CNBG Recombinant Vector Vaccines Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2020-2022)

Table 118. CNBG Main Business

Table 119. CNBG Latest Developments

Table 120. ChengDa Bio Basic Information, Recombinant Vector Vaccines Manufacturing Base, Sales Area and Its Competitors

Table 121. ChengDa Bio Recombinant Vector Vaccines Product Offered

Table 122. ChengDa Bio Recombinant Vector Vaccines Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2020-2022)

Table 123. ChengDa Bio Main Business

Table 124. ChengDa Bio Latest Developments

Table 125. Changsheng Life Basic Information, Recombinant Vector Vaccines Manufacturing Base, Sales Area and Its Competitors

Table 126. Changsheng Life Recombinant Vector Vaccines Product Offered

Table 127. Changsheng Life Recombinant Vector Vaccines Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2020-2022)

Table 128. Changsheng Life Main Business

Table 129. Changsheng Life Latest Developments

Table 130. Zhifei Basic Information, Recombinant Vector Vaccines Manufacturing Base, Sales Area and Its Competitors

Table 131. Zhifei Recombinant Vector Vaccines Product Offered

Table 132. Zhifei Recombinant Vector Vaccines Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2020-2022)

Table 133. Zhifei Main Business

Table 134. Zhifei Latest Developments

Table 135. SINOVAC BIOTECH Basic Information, Recombinant Vector Vaccines Manufacturing Base, Sales Area and Its Competitors

Table 136. SINOVAC BIOTECH Recombinant Vector Vaccines Product Offered

Table 137. SINOVAC BIOTECH Recombinant Vector Vaccines Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2020-2022)

Table 138. SINOVAC BIOTECH Main Business

Table 139. SINOVAC BIOTECH Latest Developments

Table 140. NuoCheng Bio Basic Information, Recombinant Vector Vaccines Manufacturing Base, Sales Area and Its Competitors

Table 141. NuoCheng Bio Recombinant Vector Vaccines Product Offered

Table 142. NuoCheng Bio Recombinant Vector Vaccines Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2020-2022)

Table 143. NuoCheng Bio Main Business

Table 144. NuoCheng Bio Latest Developments

Table 145. Hualan Bio Basic Information, Recombinant Vector Vaccines Manufacturing Base, Sales Area and Its Competitors

Table 146. Hualan Bio Recombinant Vector Vaccines Product Offered

Table 147. Hualan Bio Recombinant Vector Vaccines Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2020-2022)

Table 148. Hualan Bio Main Business

Table 149. Hualan Bio Latest Developments

Table 150. Kangtai Basic Information, Recombinant Vector Vaccines Manufacturing Base, Sales Area and Its Competitors

Table 151. Kangtai Recombinant Vector Vaccines Product Offered

Table 152. Kangtai Recombinant Vector Vaccines Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2020-2022)

Table 153. Kangtai Main Business

Table 154. Kangtai Latest Developments

List of Figures

Figure 1. Picture of Recombinant Vector Vaccines

Figure 2. Recombinant Vector Vaccines Report Years Considered

Figure 3. Research Objectives

Figure 4. Research Methodology

Figure 5. Research Process and Data Source

Figure 6. Global Recombinant Vector Vaccines Sales Growth Rate 2017-2028 (K Doses)

Figure 7. Global Recombinant Vector Vaccines Revenue Growth Rate 2017-2028 ($ Millions)

Figure 8. Recombinant Vector Vaccines Sales by Region (2021 & 2028) & ($ millions)

Figure 9. Product Picture of Varicella

Figure 10. Product Picture of Influenza

Figure 11. Product Picture of Polio

Figure 12. Product Picture of Hepatitis A

Figure 13. Product Picture of Rabies

Figure 14. Product Picture of BCG

Figure 15. Product Picture of Hepatitis B

Figure 16. Product Picture of Pertussis, Diphtheria, tetanus

Figure 17. Product Picture of Pneumococcal

Figure 18. Product Picture of Others

Figure 19. Global Recombinant Vector Vaccines Sales Market Share by Type in 2021

Figure 20. Global Recombinant Vector Vaccines Revenue Market Share by Type (2017-2022)

Figure 21. Recombinant Vector Vaccines Consumed in For Adult

Figure 22. Global Recombinant Vector Vaccines Market: For Adult (2017-2022) & (K Doses)

Figure 23. Recombinant Vector Vaccines Consumed in For Child

Figure 24. Global Recombinant Vector Vaccines Market: For Child (2017-2022) & (K Doses)

Figure 25. Global Recombinant Vector Vaccines Sales Market Share by Application (2017-2022)

Figure 26. Global Recombinant Vector Vaccines Revenue Market Share by Application in 2021

Figure 27. Recombinant Vector Vaccines Revenue Market by Company in 2021 ($ Million)

Figure 28. Global Recombinant Vector Vaccines Revenue Market Share by Company in 2021

Figure 29. Global Recombinant Vector Vaccines Sales Market Share by Geographic Region (2017-2022)

Figure 30. Global Recombinant Vector Vaccines Revenue Market Share by Geographic Region in 2021

Figure 31. Global Recombinant Vector Vaccines Sales Market Share by Region (2017-2022)

Figure 32. Global Recombinant Vector Vaccines Revenue Market Share by Country/Region in 2021

Figure 33. Americas Recombinant Vector Vaccines Sales 2017-2022 (K Doses)

Figure 34. Americas Recombinant Vector Vaccines Revenue 2017-2022 ($ Millions)

Figure 35. APAC Recombinant Vector Vaccines Sales 2017-2022 (K Doses)

Figure 36. APAC Recombinant Vector Vaccines Revenue 2017-2022 ($ Millions)

Figure 37. Europe Recombinant Vector Vaccines Sales 2017-2022 (K Doses)

Figure 38. Europe Recombinant Vector Vaccines Revenue 2017-2022 ($ Millions)

Figure 39. Middle East & Africa Recombinant Vector Vaccines Sales 2017-2022 (K Doses)

Figure 40. Middle East & Africa Recombinant Vector Vaccines Revenue 2017-2022 ($ Millions)

Figure 41. Americas Recombinant Vector Vaccines Sales Market Share by Country in 2021

Figure 42. Americas Recombinant Vector Vaccines Revenue Market Share by Country in 2021

Figure 43. United States Recombinant Vector Vaccines Revenue Growth 2017-2022 ($ Millions)

Figure 44. Canada Recombinant Vector Vaccines Revenue Growth 2017-2022 ($ Millions)

Figure 45. Mexico Recombinant Vector Vaccines Revenue Growth 2017-2022 ($ Millions)

Figure 46. Brazil Recombinant Vector Vaccines Revenue Growth 2017-2022 ($ Millions)

Figure 47. APAC Recombinant Vector Vaccines Sales Market Share by Region in 2021

Figure 48. APAC Recombinant Vector Vaccines Revenue Market Share by Regions in 2021

Figure 49. China Recombinant Vector Vaccines Revenue Growth 2017-2022 ($ Millions)

Figure 50. Japan Recombinant Vector Vaccines Revenue Growth 2017-2022 ($ Millions)

Figure 51. South Korea Recombinant Vector Vaccines Revenue Growth 2017-2022 ($ Millions)

Figure 52. Southeast Asia Recombinant Vector Vaccines Revenue Growth 2017-2022 ($ Millions)

Figure 53. India Recombinant Vector Vaccines Revenue Growth 2017-2022 ($ Millions)

Figure 54. Australia Recombinant Vector Vaccines Revenue Growth 2017-2022 ($ Millions)

Figure 55. Europe Recombinant Vector Vaccines Sales Market Share by Country in 2021

Figure 56. Europe Recombinant Vector Vaccines Revenue Market Share by Country in 2021

Figure 57. Germany Recombinant Vector Vaccines Revenue Growth 2017-2022 ($ Millions)

Figure 58. France Recombinant Vector Vaccines Revenue Growth 2017-2022 ($ Millions)

Figure 59. UK Recombinant Vector Vaccines Revenue Growth 2017-2022 ($ Millions)

Figure 60. Italy Recombinant Vector Vaccines Revenue Growth 2017-2022 ($ Millions)

Figure 61. Russia Recombinant Vector Vaccines Revenue Growth 2017-2022 ($ Millions)

Figure 62. Middle East & Africa Recombinant Vector Vaccines Sales Market Share by Country in 2021

Figure 63. Middle East & Africa Recombinant Vector Vaccines Revenue Market Share by Country in 2021

Figure 64. Egypt Recombinant Vector Vaccines Revenue Growth 2017-2022 ($ Millions)

Figure 65. South Africa Recombinant Vector Vaccines Revenue Growth 2017-2022 ($ Millions)

Figure 66. Israel Recombinant Vector Vaccines Revenue Growth 2017-2022 ($ Millions)

Figure 67. Turkey Recombinant Vector Vaccines Revenue Growth 2017-2022 ($ Millions)

Figure 68. GCC Country Recombinant Vector Vaccines Revenue Growth 2017-2022 ($ Millions)

Figure 69. Manufacturing Cost Structure Analysis of Recombinant Vector Vaccines in 2021

Figure 70. Manufacturing Process Analysis of Recombinant Vector Vaccines

Figure 71. Industry Chain Structure of Recombinant Vector Vaccines

Figure 72. Channels of Distribution

Figure 73. Distributors Profiles